Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
cytochrome P450 family 3 subfamily A polypeptide 4 | 17 | 0 | 0 | 17 |
EWS/FLI fusion protein | 13 | 0 | 0 | 13 |
G | 11 | 0 | 0 | 11 |
cytochrome P450 2D6 | 8 | 0 | 0 | 8 |
Potassium voltage-gated channel subfamily KQT member 3 | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily KQT member 2 | 0 | 1 | 0 | 1 |
Interferon beta | 15 | 0 | 0 | 15 |
HLA class I histocompatibility antigen, B alpha chain | 11 | 0 | 0 | 11 |
Muscarinic acetylcholine receptor M2 | 0 | 5 | 2 | 11 |
Muscarinic acetylcholine receptor M4 | 0 | 5 | 1 | 9 |
5-hydroxytryptamine receptor 1A | 0 | 3 | 0 | 3 |
Muscarinic acetylcholine receptor M5 | 0 | 4 | 1 | 8 |
Alpha-2A adrenergic receptor | 0 | 9 | 3 | 14 |
Adenosine receptor A3 | 0 | 6 | 1 | 7 |
Muscarinic acetylcholine receptor M1 | 0 | 6 | 2 | 12 |
D(2) dopamine receptor | 0 | 3 | 1 | 4 |
Alpha-2B adrenergic receptor | 0 | 10 | 1 | 13 |
Muscarinic acetylcholine receptor M3 | 0 | 5 | 2 | 10 |
Cannabinoid receptor 1 | 0 | 1 | 0 | 1 |
D(1A) dopamine receptor | 0 | 4 | 1 | 5 |
D(4) dopamine receptor | 0 | 3 | 0 | 3 |
D(1B) dopamine receptor | 0 | 1 | 0 | 1 |
Histamine H2 receptor | 0 | 2 | 2 | 4 |
C-X-C chemokine receptor type 2 | 0 | 1 | 0 | 1 |
Endothelin-1 receptor | 0 | 4 | 1 | 6 |
Adenosine receptor A1 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1B | 0 | 4 | 1 | 5 |
5-hydroxytryptamine receptor 2A | 0 | 3 | 1 | 4 |
5-hydroxytryptamine receptor 2C | 0 | 9 | 1 | 10 |
Adenosine receptor A2a | 0 | 3 | 1 | 4 |
Translocator protein | 0 | 2 | 0 | 2 |
Adenosine receptor A1 | 0 | 3 | 0 | 3 |
Cholecystokinin receptor type A | 0 | 2 | 1 | 3 |
C-C chemokine receptor type 1 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 7 | 0 | 2 | 1 | 3 |
Cannabinoid receptor 2 | 0 | 1 | 0 | 1 |
Histamine H1 receptor | 0 | 6 | 2 | 8 |
Alpha-1B adrenergic receptor | 0 | 4 | 2 | 10 |
Mu-type opioid receptor | 0 | 7 | 4 | 12 |
D(3) dopamine receptor | 0 | 5 | 0 | 5 |
Delta-type opioid receptor | 0 | 7 | 2 | 10 |
Kappa-type opioid receptor | 0 | 8 | 2 | 11 |
Nociceptin receptor | 0 | 1 | 0 | 1 |
P2Y purinoceptor 2 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 3A | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 5A | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 6 | 0 | 3 | 1 | 4 |
P2X purinoceptor 3 | 0 | 1 | 0 | 1 |
Voltage-dependent N-type calcium channel subunit alpha-1B | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily H member 2 | 0 | 16 | 0 | 16 |
Sodium channel protein type 5 subunit alpha | 0 | 4 | 0 | 4 |
Sodium channel protein type 9 subunit alpha | 0 | 3 | 0 | 3 |
Sodium channel protein type 10 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 10 subunit alpha | 0 | 1 | 0 | 1 |
Transient receptor potential cation channel subfamily V member 1 | 0 | 1 | 0 | 1 |
Inositol hexakisphosphate kinase 1 | 11 | 0 | 0 | 11 |
Sodium channel protein type 2 subunit alpha | 0 | 3 | 0 | 3 |
Sigma non-opioid intracellular receptor 1 | 0 | 11 | 0 | 11 |
Sodium channel protein type 3 subunit alpha | 0 | 4 | 0 | 4 |
P2X purinoceptor 2 | 0 | 1 | 0 | 1 |
Sodium channel protein type 10 subunit alpha | 0 | 2 | 0 | 2 |
cytochrome P450 2C9, partial | 11 | 0 | 0 | 11 |
RAR-related orphan receptor gamma | 14 | 0 | 0 | 14 |
ATAD5 protein, partial | 9 | 0 | 0 | 9 |
GLS protein | 8 | 0 | 0 | 8 |
Microtubule-associated protein tau | 12 | 0 | 0 | 12 |
Smad3 | 4 | 0 | 0 | 4 |
aldehyde dehydrogenase 1 family, member A1 | 11 | 0 | 0 | 11 |
thyroid stimulating hormone receptor | 7 | 0 | 0 | 7 |
nuclear receptor subfamily 1, group I, member 3 | 11 | 0 | 0 | 11 |
progesterone receptor | 12 | 0 | 0 | 12 |
retinoic acid nuclear receptor alpha variant 1 | 12 | 0 | 0 | 12 |
retinoid X nuclear receptor alpha | 13 | 0 | 0 | 13 |
estrogen-related nuclear receptor alpha | 14 | 0 | 0 | 14 |
estrogen nuclear receptor alpha | 24 | 0 | 0 | 24 |
peroxisome proliferator activated receptor gamma | 12 | 0 | 0 | 12 |
aryl hydrocarbon receptor | 7 | 0 | 0 | 7 |
chromobox protein homolog 1 | 10 | 0 | 0 | 10 |
thyroid hormone receptor beta isoform 2 | 18 | 0 | 0 | 18 |
peripheral myelin protein 22 | 9 | 0 | 0 | 9 |
cytochrome P450 3A4 isoform 1 | 9 | 0 | 0 | 9 |
Gamma-aminobutyric acid receptor subunit pi | 9 | 6 | 2 | 17 |
ATP-binding cassette sub-family C member 3 | 0 | 16 | 0 | 16 |
Multidrug resistance-associated protein 4 | 0 | 16 | 0 | 17 |
Solute carrier family 22 member 6 | 0 | 5 | 0 | 5 |
Carbonic anhydrase 12 | 0 | 6 | 1 | 11 |
UDP-glucuronosyltransferase 1A9 | 0 | 0 | 0 | 1 |
Bile salt export pump | 0 | 5 | 0 | 5 |
Voltage-dependent calcium channel gamma-2 subunit | 9 | 0 | 0 | 9 |
Bile salt export pump | 0 | 28 | 0 | 28 |
Cytochrome P450 2B1 | 0 | 0 | 0 | 1 |
Cytochrome P450 1A1 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 1 | 0 | 7 | 1 | 14 |
Carbonic anhydrase 2 | 0 | 7 | 1 | 14 |
Myoglobin | 0 | 1 | 0 | 1 |
Cytochrome P450 1A1 | 0 | 0 | 1 | 2 |
Cytochrome P450 1A2 | 0 | 3 | 0 | 4 |
Prostaglandin G/H synthase 1 | 0 | 5 | 0 | 6 |
Carbonic anhydrase 3 | 0 | 6 | 1 | 10 |
Cytochrome P450 3A4 | 0 | 10 | 2 | 12 |
Cytochrome P450 2D6 | 0 | 6 | 0 | 6 |
Cytochrome P450 2C9 | 0 | 8 | 0 | 8 |
Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 4 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit beta-1 | 9 | 6 | 2 | 17 |
Sulfotransferase 1A1 | 0 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit delta | 9 | 6 | 2 | 17 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 9 | 6 | 2 | 17 |
UDP-glucuronosyltransferase 1-6 | 0 | 1 | 0 | 2 |
Glutamate receptor 2 | 9 | 0 | 0 | 9 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 9 | 6 | 2 | 17 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 9 | 6 | 2 | 17 |
Arachidonate 5-lipoxygenase-activating protein | 0 | 3 | 0 | 3 |
UDP-glucuronosyltransferase 1A1 | 0 | 1 | 0 | 2 |
Carbonic anhydrase 4 | 0 | 6 | 1 | 10 |
Prostaglandin G/H synthase 1 | 0 | 4 | 0 | 5 |
Carbonic anhydrase 6 | 0 | 6 | 1 | 10 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 9 | 6 | 2 | 17 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 9 | 6 | 2 | 17 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 9 | 6 | 2 | 17 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 9 | 6 | 2 | 17 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 9 | 6 | 2 | 17 |
Carbonic anhydrase 5A, mitochondrial | 0 | 6 | 1 | 11 |
Prostaglandin G/H synthase 2 | 0 | 6 | 2 | 10 |
Carbonic anhydrase 7 | 0 | 6 | 1 | 10 |
Nuclear receptor ROR-gamma | 6 | 1 | 1 | 8 |
Cytochrome P450 2J2 | 0 | 6 | 0 | 6 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 9 | 7 | 2 | 18 |
Gamma-aminobutyric acid receptor subunit beta-3 | 9 | 6 | 2 | 17 |
Gamma-aminobutyric acid receptor subunit beta-2 | 9 | 6 | 2 | 17 |
Carbonic anhydrase 9 | 0 | 7 | 1 | 12 |
GABA theta subunit | 9 | 6 | 2 | 17 |
Canalicular multispecific organic anion transporter 1 | 0 | 14 | 0 | 14 |
Carbonic anhydrase 15 | 0 | 4 | 0 | 6 |
Carbonic anhydrase 13 | 0 | 4 | 0 | 7 |
Gamma-aminobutyric acid receptor subunit epsilon | 9 | 6 | 2 | 17 |
Carbonic anhydrase 14 | 0 | 6 | 1 | 11 |
Carbonic anhydrase 5B, mitochondrial | 0 | 6 | 1 | 11 |
toxin B | 0 | 0 | 0 | 1 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 5 | 0 | 0 | 5 |
Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
Chain A, Carbonic Anhydrase Ii | 0 | 0 | 1 | 1 |
Chain A, Carbonic Anhydrase Ii | 0 | 0 | 1 | 1 |
Chain A, Beta-lactamase | 5 | 0 | 0 | 5 |
Chain A, Endochitinase | 0 | 1 | 0 | 1 |
Chain A, Endochitinase | 0 | 1 | 0 | 1 |
Chain A, Endochitinase | 0 | 1 | 0 | 1 |
Chain A, Class Iii Chitinase Chia1 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 13 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase II | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase | 0 | 1 | 0 | 1 |
Chain B, Carbonic anhydrase | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 0 | 0 | 2 |
Carbonic anhydrase | 0 | 2 | 0 | 2 |
thioredoxin reductase | 10 | 0 | 0 | 10 |
GALC protein | 3 | 0 | 0 | 3 |
GLI family zinc finger 3 | 15 | 0 | 0 | 15 |
glucocorticoid receptor [Homo sapiens] | 20 | 0 | 0 | 20 |
Carbonic anhydrase | 0 | 2 | 0 | 2 |
Carbonic anhydrase | 0 | 2 | 0 | 2 |
arylsulfatase A | 5 | 0 | 0 | 5 |
Carbonic anhydrase | 0 | 2 | 0 | 2 |
euchromatic histone-lysine N-methyltransferase 2 | 18 | 0 | 0 | 18 |
Bloom syndrome protein isoform 1 | 4 | 0 | 0 | 4 |
thyroid hormone receptor beta isoform a | 6 | 0 | 0 | 6 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 13 | 0 | 0 | 13 |
geminin | 17 | 0 | 0 | 17 |
survival motor neuron protein isoform d | 5 | 0 | 0 | 5 |
muscleblind-like protein 1 isoform 1 | 4 | 0 | 0 | 4 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Prolyl endopeptidase | 0 | 1 | 0 | 1 |
Carbonic anhydrase-related protein 11 | 0 | 1 | 0 | 2 |
Glycogen phosphorylase, muscle form | 0 | 1 | 0 | 1 |
Renin | 0 | 3 | 0 | 3 |
Carbonic anhydrase 2 | 0 | 2 | 0 | 2 |
Cathepsin B | 0 | 1 | 0 | 1 |
Steryl-sulfatase | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2C | 0 | 3 | 0 | 3 |
Polyunsaturated fatty acid 5-lipoxygenase | 0 | 3 | 0 | 3 |
Cytochrome P450 2C8 | 0 | 4 | 0 | 4 |
Cytochrome P450 2A6 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2A | 0 | 4 | 0 | 4 |
Androgen receptor | 0 | 6 | 0 | 6 |
Translocator protein | 0 | 3 | 2 | 6 |
Cannabinoid receptor 1 | 0 | 1 | 0 | 1 |
Cytochrome P450 2B6 | 0 | 4 | 0 | 4 |
Carbonic anhydrase 5A, mitochondrial | 0 | 1 | 0 | 1 |
Adenosine receptor A1 | 0 | 3 | 0 | 4 |
Serum paraoxonase/arylesterase 1 | 0 | 3 | 0 | 3 |
Dipeptidyl peptidase 4 | 0 | 0 | 0 | 1 |
Endochitinase | 0 | 1 | 0 | 1 |
Adenosine receptor A2a | 0 | 3 | 0 | 4 |
5-hydroxytryptamine receptor 2B | 0 | 2 | 0 | 2 |
Sodium-dependent serotonin transporter | 0 | 3 | 1 | 4 |
Delta-type opioid receptor | 0 | 6 | 0 | 7 |
Cytochrome P450 2C19 | 0 | 6 | 0 | 6 |
Delta-type opioid receptor | 0 | 7 | 1 | 9 |
Mu-type opioid receptor | 0 | 6 | 2 | 11 |
Carbonic anhydrase | 0 | 2 | 0 | 3 |
Kappa-type opioid receptor | 0 | 6 | 0 | 6 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
D(1A) dopamine receptor | 2 | 1 | 0 | 3 |
Corticosteroid 11-beta-dehydrogenase isozyme 1 | 0 | 2 | 0 | 2 |
Carbonic anhydrase | 0 | 2 | 0 | 4 |
D(2) dopamine receptor | 0 | 4 | 0 | 4 |
Cholinesterase | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 2 | 0 | 2 |
Mu-type opioid receptor | 0 | 9 | 1 | 10 |
Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
Beta-carbonic anhydrase 1 | 0 | 2 | 0 | 2 |
Carbonic anhydrase 2 | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 1 | 0 | 2 |
Squalene synthase | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-7 | 0 | 2 | 0 | 2 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase, alpha family | 0 | 2 | 0 | 2 |
Carbonic anhydrase | 0 | 2 | 0 | 4 |
Carbonic anhydrase 3 | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 2 | 0 | 5 |
Carbonic anhydrase | 0 | 2 | 0 | 5 |
Carbonic anhydrase | 0 | 2 | 0 | 2 |
Sigma intracellular receptor 2 | 0 | 3 | 0 | 3 |
Delta carbonic anhydrase | 0 | 2 | 0 | 2 |
Sigma non-opioid intracellular receptor 1 | 0 | 3 | 0 | 3 |
Renin | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 2 | 0 | 4 |
Endochitinase A1 | 0 | 1 | 0 | 1 |
Multidrug resistance-associated protein 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 13 | 0 | 4 | 1 | 7 |
Carbonic anhydrase 4 | 0 | 4 | 0 | 5 |
Acidic mammalian chitinase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 7 | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 2, isoform A | 0 | 1 | 0 | 1 |
Chain A, JmjC domain-containing histone demethylation protein 3A | 4 | 0 | 0 | 4 |
Chain A, 2-oxoglutarate Oxygenase | 11 | 0 | 0 | 11 |
Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 2 | 0 | 0 | 2 |
acetylcholinesterase | 7 | 0 | 0 | 7 |
dopamine D1 receptor | 2 | 0 | 0 | 2 |
15-lipoxygenase, partial | 4 | 0 | 0 | 4 |
pregnane X receptor | 5 | 0 | 0 | 5 |
phosphopantetheinyl transferase | 7 | 0 | 0 | 7 |
USP1 protein, partial | 14 | 0 | 0 | 14 |
NFKB1 protein, partial | 2 | 0 | 0 | 2 |
Thrombopoietin | 4 | 0 | 0 | 4 |
AR protein | 26 | 0 | 0 | 26 |
regulator of G-protein signaling 4 | 5 | 0 | 0 | 5 |
farnesoid X nuclear receptor | 11 | 0 | 0 | 11 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 12 | 0 | 0 | 12 |
D(1A) dopamine receptor | 5 | 0 | 0 | 5 |
heat shock protein beta-1 | 7 | 0 | 0 | 7 |
flap endonuclease 1 | 4 | 0 | 0 | 4 |
muscarinic acetylcholine receptor M1 | 4 | 0 | 0 | 4 |
Histone deacetylase 3 | 0 | 4 | 0 | 4 |
Histone deacetylase 4 | 0 | 3 | 0 | 3 |
Guanine nucleotide-binding protein G | 3 | 0 | 0 | 3 |
Histone deacetylase 1 | 0 | 4 | 0 | 4 |
Histone deacetylase 7 | 0 | 3 | 0 | 3 |
Histone deacetylase 2 | 0 | 4 | 0 | 4 |
Polyamine deacetylase HDAC10 | 0 | 2 | 0 | 2 |
Histone deacetylase 11 | 0 | 3 | 0 | 3 |
Ataxin-2 | 15 | 0 | 0 | 15 |
Histone deacetylase 8 | 0 | 3 | 0 | 3 |
Histone deacetylase 6 | 0 | 3 | 0 | 3 |
Histone deacetylase 9 | 0 | 2 | 0 | 2 |
Histone deacetylase 5 | 0 | 3 | 0 | 3 |
ATP-dependent phosphofructokinase | 5 | 0 | 0 | 5 |
Chain A, HADH2 protein | 6 | 0 | 0 | 6 |
Chain B, HADH2 protein | 6 | 0 | 0 | 6 |
cellular tumor antigen p53 isoform a | 6 | 0 | 0 | 6 |
cytochrome P450 2C9 precursor | 5 | 0 | 0 | 5 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 5 | 0 | 0 | 5 |
lethal factor (plasmid) | 6 | 0 | 0 | 6 |
Prostaglandin E2 receptor EP1 subtype | 0 | 3 | 1 | 4 |
Prostaglandin E2 receptor EP4 subtype | 0 | 3 | 1 | 4 |
Prostaglandin E2 receptor EP3 subtype | 0 | 3 | 1 | 4 |
Prostaglandin E2 receptor EP2 subtype | 0 | 3 | 1 | 4 |
Prostacyclin receptor | 0 | 3 | 1 | 4 |
Histamine H2 receptor | 6 | 0 | 1 | 8 |
Prostaglandin D2 receptor | 0 | 1 | 0 | 1 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 7 | 0 | 0 | 7 |
Sex hormone-binding globulin | 0 | 0 | 1 | 1 |
Corticosteroid-binding globulin | 0 | 1 | 0 | 1 |
Mineralocorticoid receptor | 0 | 1 | 2 | 3 |
Mineralocorticoid receptor | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1A1 | 0 | 0 | 0 | 2 |
glucocerebrosidase | 3 | 0 | 0 | 3 |
DNA polymerase kappa isoform 1 | 6 | 0 | 0 | 6 |
histone acetyltransferase KAT2A isoform 1 | 3 | 0 | 0 | 3 |
Atrial natriuretic peptide receptor 3 | 0 | 1 | 0 | 1 |
Type-1A angiotensin II receptor | 0 | 2 | 1 | 3 |
Type-1 angiotensin II receptor | 0 | 0 | 1 | 1 |
Type-1B angiotensin II receptor | 0 | 2 | 0 | 2 |
Type-1 angiotensin II receptor | 0 | 3 | 3 | 6 |
Type-2 angiotensin II receptor | 0 | 2 | 0 | 2 |
Type-2 angiotensin II receptor | 0 | 2 | 0 | 2 |
TDP1 protein | 21 | 0 | 0 | 21 |
cytochrome P450 2D6 isoform 1 | 5 | 0 | 0 | 5 |
histone-lysine N-methyltransferase 2A isoform 2 precursor | 4 | 0 | 0 | 4 |
lamin isoform A-delta10 | 14 | 0 | 0 | 14 |
Histamine H1 receptor | 0 | 1 | 3 | 4 |
Inositol monophosphatase 1 | 3 | 0 | 0 | 3 |
Solute carrier family 15 member 1 | 0 | 1 | 0 | 1 |
Chain A, Putative fructose-1,6-bisphosphate aldolase | 5 | 0 | 0 | 5 |
glp-1 receptor, partial | 5 | 0 | 0 | 5 |
parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 3 | 0 | 0 | 3 |
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 1 | 0 | 0 | 1 |
urokinase-type plasminogen activator precursor | 2 | 0 | 0 | 2 |
plasminogen precursor | 2 | 0 | 0 | 2 |
urokinase plasminogen activator surface receptor precursor | 2 | 0 | 0 | 2 |
nuclear receptor ROR-gamma isoform 1 | 9 | 0 | 0 | 9 |
DNA dC->dU-editing enzyme APOBEC-3F isoform a | 1 | 0 | 0 | 1 |
Cyclin-dependent kinase 2 | 0 | 1 | 0 | 1 |
pregnane X nuclear receptor | 11 | 0 | 0 | 11 |
cystic fibrosis transmembrane conductance regulator | 0 | 1 | 0 | 1 |
DNA polymerase beta | 2 | 0 | 0 | 2 |
short transient receptor potential channel 6 isoform 1 | 0 | 0 | 1 | 1 |
Solute carrier family 22 member 1 | 0 | 8 | 0 | 10 |
5-hydroxytryptamine receptor 4 | 0 | 8 | 0 | 8 |
Muscarinic acetylcholine receptor M1 | 0 | 5 | 1 | 8 |
Muscarinic acetylcholine receptor M3 | 0 | 4 | 1 | 7 |
Muscarinic acetylcholine receptor M4 | 0 | 4 | 1 | 7 |
Muscarinic acetylcholine receptor M5 | 0 | 4 | 1 | 7 |
Muscarinic acetylcholine receptor M2 | 0 | 5 | 2 | 10 |
Muscarinic acetylcholine receptor M1 | 0 | 0 | 0 | 1 |
Alpha-1D adrenergic receptor | 0 | 8 | 2 | 14 |
Muscarinic acetylcholine receptor M4 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 7 | 0 | 4 | 0 | 4 |
Reverse transcriptase/RNaseH | 0 | 0 | 0 | 1 |
Muscarinic acetylcholine receptor | 0 | 1 | 1 | 2 |
Chain A, Cruzipain | 5 | 0 | 0 | 5 |
vitamin D3 receptor isoform VDRA | 6 | 0 | 0 | 6 |
caspase-1 isoform alpha precursor | 1 | 0 | 0 | 1 |
Caspase-7 | 1 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 1B3 | 0 | 5 | 0 | 6 |
Solute carrier organic anion transporter family member 1B1 | 0 | 6 | 0 | 7 |
Solute carrier organic anion transporter family member 1A4 | 0 | 1 | 0 | 3 |
Multidrug resistance-associated protein 6 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 1A5 | 0 | 0 | 0 | 2 |
Endothelin receptor type B | 0 | 1 | 0 | 1 |
Endothelin-1 receptor | 0 | 1 | 0 | 1 |
Endothelin-1 receptor | 0 | 1 | 0 | 1 |
Canalicular multispecific organic anion transporter 1 | 0 | 1 | 0 | 2 |
Solute carrier organic anion transporter family member 1B2 | 0 | 0 | 0 | 2 |
Chain A, angiotensin converting enzyme | 0 | 1 | 0 | 1 |
Chain A, angiotensin converting enzyme | 0 | 1 | 0 | 1 |
thioredoxin glutathione reductase | 2 | 0 | 0 | 2 |
Metallo-beta-lactamase type 2 | 0 | 1 | 1 | 2 |
peripheral myelin protein 22 isoform 1 | 3 | 0 | 0 | 3 |
M-phase phosphoprotein 8 | 3 | 0 | 0 | 3 |
transient receptor potential cation channel subfamily V member 1 | 1 | 0 | 0 | 1 |
Prothrombin | 0 | 1 | 0 | 1 |
Neprilysin | 0 | 1 | 0 | 1 |
Neprilysin | 0 | 1 | 0 | 1 |
Leukotriene A-4 hydrolase | 0 | 3 | 1 | 4 |
EEF1AKMT4-ECE2 readthrough transcript protein | 0 | 1 | 0 | 1 |
Angiotensin-converting enzyme | 0 | 2 | 1 | 3 |
Angiotensin-converting enzyme | 0 | 6 | 0 | 7 |
Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
Thymidine phosphorylase | 0 | 0 | 1 | 1 |
Endothelin-converting enzyme 1 | 0 | 1 | 0 | 1 |
Succinyl-diaminopimelate desuccinylase | 0 | 2 | 0 | 2 |
Angiotensin-converting enzyme | 0 | 2 | 0 | 2 |
Solute carrier family 15 member 1 | 0 | 1 | 0 | 1 |
Beta-lactamase TEM | 0 | 1 | 0 | 1 |
TAR DNA-binding protein 43 | 2 | 0 | 0 | 2 |
Beta-lactamase | 0 | 2 | 0 | 3 |
Beta-lactamase | 0 | 2 | 0 | 2 |
Angiotensin-converting enzyme 2 | 0 | 1 | 1 | 2 |
Beta-lactamase class B VIM-2 | 0 | 1 | 1 | 2 |
Solute carrier family 22 member 5 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 5 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 16 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 21 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 5 | 0 | 0 | 0 | 1 |
Chain A, Carbonic anhydrase II | 0 | 1 | 0 | 1 |
GTP-binding protein (rab7) | 0 | 0 | 1 | 1 |
ras protein, partial | 0 | 0 | 1 | 1 |
hypoxia-inducible factor 1 alpha subunit | 8 | 0 | 0 | 8 |
SMAD family member 2 | 5 | 0 | 0 | 5 |
PPM1D protein | 5 | 0 | 0 | 5 |
SMAD family member 3 | 5 | 0 | 0 | 5 |
caspase 7, apoptosis-related cysteine protease | 3 | 0 | 0 | 3 |
estrogen receptor 2 (ER beta) | 10 | 0 | 0 | 10 |
67.9K protein | 6 | 0 | 0 | 6 |
peroxisome proliferator-activated receptor delta | 7 | 0 | 0 | 7 |
Rac1 protein | 0 | 0 | 1 | 1 |
caspase-3 | 3 | 0 | 0 | 3 |
IDH1 | 7 | 0 | 0 | 7 |
cell division cycle 42 (GTP binding protein, 25kDa), partial | 0 | 0 | 1 | 1 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 13 | 0 | 0 | 13 |
thyroid stimulating hormone receptor | 7 | 0 | 0 | 7 |
activating transcription factor 6 | 9 | 0 | 0 | 9 |
thyrotropin-releasing hormone receptor | 3 | 0 | 0 | 3 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 8 | 0 | 0 | 8 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 7 | 0 | 0 | 7 |
Histone H2A.x | 5 | 0 | 0 | 5 |
Caspase-7 | 2 | 0 | 0 | 2 |
interferon gamma precursor | 0 | 0 | 0 | 2 |
prostaglandin E2 receptor EP2 subtype | 1 | 0 | 0 | 2 |
potassium voltage-gated channel subfamily H member 2 isoform d | 6 | 0 | 0 | 6 |
caspase-3 | 2 | 0 | 0 | 2 |
Prostaglandin E synthase | 0 | 3 | 0 | 3 |
3-phosphoinositide-dependent protein kinase 1 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 2 | 0 | 3 |
Prostaglandin G/H synthase 2 | 0 | 2 | 0 | 3 |
cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
Cytochrome c oxidase subunit 1 | 0 | 1 | 0 | 1 |
Cytochrome c oxidase subunit 2 | 0 | 1 | 0 | 1 |
Catechol O-methyltransferase | 0 | 1 | 0 | 1 |
Cytochrome c oxidase subunit 2 | 0 | 2 | 0 | 2 |
Cellular tumor antigen p53 | 16 | 0 | 0 | 16 |
Procathepsin L | 0 | 2 | 1 | 3 |
Aldo-keto reductase family 1 member B1 | 0 | 4 | 0 | 4 |
Seed linoleate 13S-lipoxygenase-1 | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-4 | 0 | 3 | 0 | 3 |
Quinolone resistance protein NorA | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit beta-2 | 0 | 3 | 0 | 3 |
Beta-3 adrenergic receptor | 0 | 4 | 1 | 5 |
Alpha-1B adrenergic receptor | 0 | 8 | 2 | 10 |
Calpain-2 catalytic subunit | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1A | 0 | 6 | 2 | 9 |
Prostaglandin G/H synthase 1 | 0 | 2 | 0 | 2 |
Sodium-dependent noradrenaline transporter | 0 | 4 | 1 | 5 |
Cruzipain | 0 | 1 | 0 | 1 |
Sodium/hydrogen exchanger 1 | 0 | 1 | 0 | 1 |
Indoleamine 2,3-dioxygenase 1 | 0 | 3 | 0 | 3 |
Sodium-dependent serotonin transporter | 0 | 10 | 1 | 11 |
Bifunctional epoxide hydrolase 2 | 0 | 2 | 0 | 2 |
Prostaglandin G/H synthase 2 | 0 | 2 | 0 | 2 |
Alpha-1A adrenergic receptor | 0 | 9 | 3 | 12 |
Urotensin-2 receptor | 0 | 1 | 0 | 1 |
Ras-related protein Rab-2A | 0 | 0 | 1 | 1 |
Prostaglandin G/H synthase 2 | 0 | 4 | 0 | 4 |
Sodium-dependent dopamine transporter | 0 | 6 | 0 | 6 |
Prostaglandin G/H synthase 2 | 0 | 2 | 0 | 3 |
Mitogen-activated protein kinase 14 | 0 | 2 | 0 | 2 |
Prostaglandin G/H synthase 1 | 0 | 2 | 0 | 2 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Cyclooxygenase-2 | 0 | 1 | 0 | 1 |
Rap guanine nucleotide exchange factor 4 | 2 | 0 | 0 | 2 |
ATPase family AAA domain-containing protein 5 | 10 | 0 | 0 | 10 |
P2Y purinoceptor 12 | 0 | 2 | 0 | 2 |
atrial natriuretic peptide receptor 1 precursor | 1 | 0 | 0 | 1 |
atrial natriuretic peptide receptor 2 precursor | 2 | 0 | 0 | 2 |
MBT domain-containing protein 1 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 1 | 0 | 2 | 0 | 3 |
Lethal(3)malignant brain tumor-like protein 4 | 0 | 1 | 0 | 1 |
Lethal(3)malignant brain tumor-like protein 3 | 0 | 1 | 0 | 1 |
Chloroquine resistance transporter | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 2 | 0 | 2 | 0 | 3 |
Lethal(3)malignant brain tumor-like protein 1 | 0 | 1 | 0 | 1 |
nonstructural protein 1 | 3 | 0 | 0 | 3 |
Liver carboxylesterase 1 | 0 | 0 | 0 | 2 |
P2Y purinoceptor 12 | 0 | 1 | 0 | 1 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 6 | 0 | 0 | 6 |
Rap guanine nucleotide exchange factor 3 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit pi | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit delta | 0 | 2 | 0 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 3 | 0 | 3 |
Fatty acid-binding protein, liver | 0 | 1 | 0 | 1 |
Alpha-1-acid glycoprotein 1 | 0 | 0 | 0 | 1 |
Albumin | 0 | 2 | 4 | 7 |
Albumin | 0 | 0 | 1 | 1 |
ATP-dependent translocase ABCB1 | 0 | 9 | 0 | 13 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 2 | 2 | 4 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 2 | 1 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit delta | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 2 | 1 | 3 |
Translocator protein | 0 | 1 | 0 | 1 |
Cholecystokinin receptor type A | 0 | 1 | 0 | 1 |
Gastrin/cholecystokinin type B receptor | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 2 | 2 | 4 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 2 | 1 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 2 | 1 | 3 |
Gamma-aminobutyric acid receptor subunit beta-2 | 0 | 2 | 1 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit epsilon | 0 | 2 | 0 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 3 | 0 | 3 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 3 | 0 | 3 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 4 | 0 | 5 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit pi | 0 | 1 | 0 | 1 |
Sphingosine-1-phosphate lyase 1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit theta | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit theta | 0 | 2 | 0 | 2 |
Fumarate hydratase | 4 | 0 | 0 | 4 |
polyprotein | 4 | 0 | 0 | 4 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 8 | 0 | 0 | 8 |
interleukin 8 | 3 | 0 | 0 | 3 |
PAX8 | 0 | 0 | 0 | 1 |
STAT3, partial | 0 | 1 | 0 | 1 |
alpha-galactosidase | 2 | 0 | 0 | 2 |
NPC intracellular cholesterol transporter 1 precursor | 4 | 0 | 0 | 4 |
tumor necrosis factor | 2 | 0 | 0 | 2 |
ras-related protein Rab-9A | 6 | 0 | 0 | 6 |
signal transducer and activator of transcription 1-alpha/beta isoform alpha | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit alpha-1 | 0 | 2 | 0 | 2 |
Sodium/potassium-transporting ATPase subunit beta-1 | 0 | 2 | 0 | 2 |
Integrin beta-3 | 5 | 0 | 0 | 5 |
Sodium/potassium-transporting ATPase subunit alpha-2 | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit alpha-3 | 0 | 1 | 0 | 1 |
ATP-dependent translocase ABCB1 | 0 | 3 | 0 | 3 |
Sodium/potassium-transporting ATPase subunit beta-1 | 0 | 1 | 0 | 1 |
Integrin alpha-IIb | 5 | 0 | 0 | 5 |
Replicase polyprotein 1ab | 0 | 2 | 2 | 4 |
Sodium/potassium-transporting ATPase subunit alpha-3 | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit beta-2 | 0 | 1 | 0 | 1 |
ATP-dependent translocase ABCB1 | 0 | 3 | 0 | 3 |
Sodium/potassium-transporting ATPase subunit alpha-2 | 0 | 2 | 0 | 2 |
Sodium/potassium-transporting ATPase subunit alpha-1 | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit beta-3 | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit gamma | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit alpha-4 | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit alpha-4 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 4C1 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 4C1 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 1A4 | 0 | 0 | 0 | 1 |
mitogen-activated protein kinase 1 | 5 | 0 | 0 | 5 |
Solute carrier family 22 member 2 | 0 | 1 | 0 | 3 |
Prostaglandin E2 receptor EP3 subtype | 0 | 2 | 0 | 2 |
Prostaglandin E2 receptor EP4 subtype | 0 | 2 | 0 | 2 |
Prostaglandin E2 receptor EP1 subtype | 0 | 2 | 0 | 2 |
Prostaglandin F2-alpha receptor | 0 | 0 | 1 | 1 |
Prostaglandin E2 receptor EP4 subtype | 0 | 1 | 1 | 2 |
Solute carrier organic anion transporter family member 2A1 | 0 | 1 | 0 | 2 |
Solute carrier family 22 member 6 | 0 | 1 | 0 | 2 |
Solute carrier family 22 member 7 | 0 | 0 | 0 | 2 |
Prostaglandin E2 receptor EP2 subtype | 0 | 2 | 0 | 2 |
Prostaglandin E2 receptor EP2 subtype | 0 | 1 | 1 | 2 |
Solute carrier family 22 member 20 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 8 | 0 | 1 | 0 | 2 |
Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 7 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 2A1 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 11 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 7 | 0 | 0 | 0 | 1 |
polyunsaturated fatty acid lipoxygenase ALOX12 | 2 | 0 | 0 | 2 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 3 | 0 | 0 | 3 |
Spike glycoprotein | 9 | 0 | 1 | 10 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 4 | 0 | 0 | 4 |
mu-type opioid receptor isoform MOR-1 | 0 | 0 | 1 | 1 |
huntingtin isoform 2 | 2 | 0 | 0 | 2 |
5-hydroxytryptamine receptor 2A | 0 | 0 | 1 | 1 |
Epidermal growth factor receptor | 0 | 2 | 0 | 2 |
Tyrosine-protein kinase Lck | 0 | 1 | 0 | 1 |
Tyrosine-protein kinase Fyn | 0 | 1 | 0 | 1 |
Beta-2 adrenergic receptor | 0 | 6 | 1 | 7 |
Beta-1 adrenergic receptor | 0 | 4 | 1 | 5 |
POU domain, class 2, transcription factor 1 | 0 | 0 | 0 | 1 |
serine/threonine-protein kinase mTOR isoform 1 | 5 | 0 | 0 | 5 |
Alpha-1A adrenergic receptor | 0 | 2 | 1 | 3 |
Interstitial collagenase | 0 | 2 | 0 | 2 |
Alpha-1A adrenergic receptor | 0 | 2 | 0 | 2 |
Alpha-2C adrenergic receptor | 0 | 8 | 2 | 12 |
Alpha-2B adrenergic receptor | 0 | 2 | 2 | 4 |
Alpha-2C adrenergic receptor | 0 | 2 | 2 | 4 |
Alpha-2A adrenergic receptor | 0 | 2 | 2 | 4 |
Alpha-1D adrenergic receptor | 0 | 4 | 2 | 6 |
Alpha-1A adrenergic receptor | 0 | 4 | 3 | 13 |
Alpha-synuclein | 1 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 2B | 0 | 6 | 1 | 7 |
Nuclear receptor subfamily 3 group C member 3 | 0 | 4 | 0 | 4 |
NS5 | 0 | 0 | 1 | 1 |
Parkin | 4 | 0 | 0 | 4 |
nuclear receptor subfamily 1, group I, member 2 | 2 | 0 | 0 | 2 |
Spike glycoprotein | 0 | 0 | 1 | 1 |
Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
Transmembrane protease serine 2 | 0 | 0 | 1 | 1 |
Glucose transporter | 0 | 1 | 0 | 1 |
Serine hydrolase RBBP9 | 0 | 1 | 0 | 1 |
Hexose transporter 1 | 0 | 1 | 0 | 1 |
Replicase polyprotein 1a | 0 | 0 | 1 | 1 |
Replicase polyprotein 1ab | 0 | 0 | 1 | 1 |
Replicase polyprotein 1ab | 0 | 1 | 1 | 2 |
Solute carrier family 2, facilitated glucose transporter member 1 | 0 | 1 | 0 | 1 |
Hypoxia-inducible factor 1-alpha | 0 | 1 | 0 | 2 |
Dihydroorotate dehydrogenase | 0 | 1 | 0 | 1 |
Endothelial PAS domain-containing protein 1 | 0 | 1 | 0 | 2 |
Luciferase | 7 | 0 | 0 | 7 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 3 | 3 |
Amine oxidase [flavin-containing] A | 0 | 1 | 0 | 1 |
Amine oxidase [flavin-containing] B | 0 | 1 | 0 | 1 |
Kappa-type opioid receptor | 0 | 3 | 1 | 5 |
Mu-type opioid receptor | 0 | 4 | 1 | 7 |
Sigma non-opioid intracellular receptor 1 | 0 | 1 | 0 | 1 |
Glucose-6-phosphate 1-dehydrogenase | 0 | 1 | 0 | 1 |
Corticosteroid 11-beta-dehydrogenase isozyme 1 | 0 | 1 | 0 | 1 |
Adenosine receptor A1 | 0 | 1 | 0 | 1 |
6-phosphogluconate dehydrogenase, decarboxylating | 0 | 1 | 0 | 1 |
Holo-[acyl-carrier-protein] synthase | 0 | 1 | 0 | 1 |
Sodium/bile acid cotransporter | 0 | 2 | 0 | 2 |
Multidrug and toxin extrusion protein 1 | 0 | 4 | 0 | 4 |
G-protein coupled receptor 35 | 0 | 1 | 1 | 2 |
CDGSH iron-sulfur domain-containing protein 1 | 0 | 2 | 0 | 2 |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 3 | 0 | 4 |
Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
Chain A, Protein (female-specific Histamine Binding Protein 2) | 0 | 0 | 1 | 1 |
aryl hydrocarbon receptor nuclear translocator | 0 | 0 | 0 | 1 |
apical membrane antigen 1, AMA1 | 2 | 0 | 0 | 2 |
bromodomain adjacent to zinc finger domain 2B | 6 | 0 | 0 | 6 |
transforming acidic coiled-coil-containing protein 3 | 0 | 0 | 0 | 1 |
DNA polymerase iota isoform a (long) | 4 | 0 | 0 | 4 |
Solute carrier family 22 member 3 | 0 | 2 | 0 | 3 |
Plasma kallikrein | 0 | 0 | 0 | 1 |
Macrophage migration inhibitory factor | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 1D | 0 | 1 | 0 | 2 |
Histamine H1 receptor | 0 | 2 | 1 | 3 |
Metabotropic glutamate receptor 5 | 0 | 1 | 1 | 2 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 0 | 0 | 1 |
Histamine H3 receptor | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 0 | 0 | 1 |
Histamine N-methyltransferase | 0 | 1 | 0 | 1 |
Glutaminyl-peptide cyclotransferase | 0 | 1 | 0 | 1 |
Carbonic anhydrase-like protein, putative | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 0 | 0 | 1 |
Equilibrative nucleoside transporter 4 | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 0 | 0 | 1 |
Histamine H4 receptor | 0 | 1 | 2 | 3 |
Histamine H4 receptor | 0 | 1 | 2 | 3 |
Histamine H4 receptor | 0 | 1 | 0 | 1 |
Histamine H4 receptor | 0 | 1 | 2 | 3 |
Histamine H3 receptor | 0 | 1 | 0 | 1 |
Carboxylic ester hydrolase | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 0 | 0 | 1 |
Histamine H3 receptor | 0 | 1 | 2 | 3 |
pyruvate kinase | 1 | 0 | 0 | 1 |
pyruvate kinase PKM isoform b | 1 | 0 | 0 | 1 |
N-glycosylase/DNA lyase | 0 | 1 | 0 | 1 |
Myeloperoxidase | 0 | 1 | 0 | 1 |
Ornithine decarboxylase | 1 | 0 | 0 | 1 |
Aspartate aminotransferase, cytoplasmic | 0 | 1 | 0 | 1 |
Lactoperoxidase | 0 | 1 | 0 | 1 |
Single-stranded DNA cytosine deaminase | 1 | 0 | 0 | 1 |
Chain A, membrane-associated prostaglandin E synthase-2 | 0 | 1 | 0 | 1 |
neuropeptide S receptor isoform A | 2 | 0 | 0 | 2 |
Prostaglandin-H2 D-isomerase | 0 | 1 | 0 | 1 |
3',5'-cyclic-AMP phosphodiesterase | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 2B1 | 0 | 2 | 0 | 2 |
Phospholipase A2, major isoenzyme | 0 | 1 | 0 | 1 |
Interleukin-8 | 0 | 1 | 0 | 1 |
Androgen receptor | 0 | 0 | 1 | 1 |
Polyunsaturated fatty acid 5-lipoxygenase | 0 | 2 | 0 | 4 |
Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member C4 | 0 | 1 | 0 | 1 |
Sodium-dependent dopamine transporter | 0 | 2 | 0 | 2 |
Sodium- and chloride-dependent GABA transporter 1 | 0 | 1 | 0 | 1 |
Thromboxane-A synthase | 0 | 2 | 0 | 2 |
Caspase-1 | 0 | 0 | 0 | 1 |
Nitric oxide synthase, inducible | 0 | 1 | 0 | 1 |
Substance-P receptor | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 2 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 3 | 0 | 1 | 0 | 1 |
Multidrug resistance-associated protein 1 | 0 | 1 | 0 | 1 |
Peroxisome proliferator-activated receptor gamma | 0 | 0 | 1 | 1 |
Aldo-keto reductase family 1 member C3 | 0 | 2 | 0 | 2 |
Sodium- and chloride-dependent betaine transporter | 0 | 1 | 0 | 1 |
C-X-C chemokine receptor type 3 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member C2 | 0 | 1 | 0 | 1 |
Prostaglandin D2 receptor | 0 | 2 | 0 | 2 |
Solute carrier organic anion transporter family member 1A3 | 0 | 1 | 0 | 1 |
Lactoylglutathione lyase | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member C1 | 0 | 1 | 0 | 1 |
Uracil nucleotide/cysteinyl leukotriene receptor | 0 | 1 | 0 | 1 |
Rho-associated protein kinase 2 | 0 | 1 | 0 | 1 |
Nicotinate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Dehydrogenase/reductase SDR family member 9 | 0 | 1 | 0 | 1 |
Cytosolic phospholipase A2 gamma | 0 | 1 | 0 | 1 |
Prostaglandin D2 receptor 2 | 0 | 1 | 1 | 2 |
tyrosine-protein kinase Yes | 1 | 0 | 0 | 1 |
streptokinase A precursor | 0 | 0 | 1 | 1 |
Estrogen receptor | 0 | 0 | 1 | 1 |
Leukotriene C4 synthase | 0 | 1 | 0 | 1 |
Macrophage-expressed gene 1 protein | 0 | 1 | 0 | 1 |
Estrogen receptor beta | 0 | 0 | 1 | 1 |
Leukotriene C4 synthase | 0 | 0 | 0 | 1 |
Prostaglandin E synthase 2 | 0 | 1 | 0 | 1 |
Leukotriene B4 receptor 1 | 0 | 2 | 0 | 3 |
Leukotriene B4 receptor 2 | 0 | 1 | 0 | 2 |
Potassium channel subfamily K member 3 | 0 | 2 | 0 | 2 |
Potassium channel subfamily K member 2 | 0 | 1 | 1 | 2 |
Sodium channel protein type 1 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 3 subunit alpha | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily A member 5 | 0 | 2 | 0 | 2 |
Sodium channel protein type 4 subunit alpha | 0 | 2 | 0 | 2 |
Potassium voltage-gated channel subfamily D member 2 | 0 | 1 | 0 | 1 |
Potassium channel subfamily K member 18 | 0 | 1 | 0 | 1 |
lethal(3)malignant brain tumor-like protein 1 isoform I | 1 | 0 | 0 | 1 |
Kappa-type opioid receptor | 0 | 3 | 1 | 5 |
Solute carrier family 22 member 3 | 0 | 1 | 0 | 1 |
Amine oxidase [flavin-containing] B | 0 | 1 | 0 | 1 |
Amine oxidase [flavin-containing] B | 0 | 1 | 0 | 1 |
Synaptic vesicular amine transporter | 0 | 1 | 0 | 1 |
Trace amine-associated receptor 1 | 0 | 0 | 1 | 1 |
Trace amine-associated receptor 1 | 0 | 0 | 1 | 1 |
Trace amine-associated receptor 1 | 0 | 0 | 1 | 1 |
Trace amine-associated receptor 1 | 0 | 0 | 1 | 1 |
Glucocorticoid receptor | 0 | 2 | 0 | 2 |
Glycine receptor subunit alpha-1 | 0 | 2 | 0 | 2 |
Glycine receptor subunit beta | 0 | 2 | 0 | 2 |
Glycine receptor subunit alpha-2 | 0 | 2 | 0 | 2 |
Glycine receptor subunit alpha-3 | 0 | 2 | 0 | 2 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
UDP-glucuronosyltransferase 2B7 | 0 | 1 | 0 | 2 |
UDP-glucuronosyltransferase 1A4 | 0 | 1 | 0 | 2 |
UDP-glucuronosyltransferase 2B10 | 0 | 1 | 0 | 1 |
Stromelysin-1 | 0 | 1 | 0 | 1 |
Matrilysin | 0 | 1 | 0 | 1 |
Multidrug transporter MdfA | 0 | 1 | 0 | 1 |
Matrix metalloproteinase-9 | 0 | 2 | 0 | 2 |
Protein mono-ADP-ribosyltransferase PARP15 | 0 | 1 | 0 | 1 |
Protein-arginine deiminase type-4 | 0 | 2 | 0 | 2 |
Nuclear receptor corepressor 1 | 0 | 1 | 0 | 1 |
Integrin beta-1 | 0 | 1 | 0 | 1 |
Integrin alpha-4 | 0 | 1 | 0 | 1 |
Nuclear receptor corepressor 2 | 0 | 1 | 0 | 1 |
Opioid receptor, delta 1b | 0 | 1 | 0 | 1 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
Opioid receptor homologue | 0 | 1 | 0 | 1 |
Acyl-CoA desaturase 1 | 0 | 1 | 0 | 1 |
Histidine decarboxylase | 0 | 0 | 1 | 1 |
Proteinase-activated receptor 1 | 0 | 1 | 1 | 2 |
UDP-glucuronosyltransferase 1A3 | 0 | 0 | 0 | 1 |
Nociceptin receptor | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 1 | 0 | 1 |
Beta-2 adrenergic receptor | 0 | 2 | 1 | 5 |
Mas-related G-protein coupled receptor member X2 | 0 | 0 | 1 | 1 |
Mu-type opioid receptor | 0 | 1 | 0 | 1 |
Atrial natriuretic peptide receptor 1 | 0 | 1 | 0 | 1 |
Neuropeptide Y receptor type 1 | 0 | 2 | 0 | 2 |
Neuropeptide Y receptor type 2 | 0 | 2 | 0 | 2 |
hypothetical protein, conserved | 1 | 0 | 0 | 1 |
beta-2 adrenergic receptor | 1 | 0 | 0 | 1 |
cytochrome P450 2C19 precursor | 2 | 0 | 0 | 2 |
perilipin-5 | 0 | 1 | 0 | 1 |
perilipin-1 | 0 | 1 | 0 | 1 |
serine/threonine-protein kinase PLK1 | 1 | 0 | 0 | 1 |
eyes absent homolog 2 isoform a | 1 | 0 | 0 | 1 |
1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform a | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 2 | 0 | 2 |
Glutathione reductase, mitochondrial | 0 | 2 | 0 | 2 |
Phospholipase A2, membrane associated | 0 | 0 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 3 | 0 | 3 |
3-oxo-5-alpha-steroid 4-dehydrogenase 1 | 0 | 1 | 0 | 1 |
Platelet-activating factor receptor | 0 | 0 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
3-oxo-5-alpha-steroid 4-dehydrogenase 2 | 0 | 1 | 0 | 1 |
Sodium channel protein type 1 subunit alpha | 0 | 2 | 0 | 2 |
C-C chemokine receptor type 2 | 0 | 2 | 0 | 2 |
Sodium channel protein type 7 subunit alpha | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily A member 1 | 0 | 1 | 0 | 1 |
C-terminal-binding protein 1 | 1 | 0 | 0 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | 0 | 1 | 0 | 1 |
Myosin light chain kinase, smooth muscle | 0 | 1 | 0 | 1 |
Transient receptor potential cation channel subfamily A member 1 | 0 | 0 | 1 | 1 |
Potassium channel subfamily K member 2 | 0 | 1 | 0 | 1 |
Indoleamine 2,3-dioxygenase 2 | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 1 | 0 | 1 |
Sodium channel protein type 11 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 8 subunit alpha | 0 | 1 | 0 | 1 |
Chain A, Ferritin light chain | 3 | 0 | 0 | 3 |
acid sphingomyelinase | 1 | 0 | 0 | 1 |
histone deacetylase 9 isoform 3 | 2 | 0 | 0 | 2 |
pyruvate kinase PKM isoform a | 1 | 0 | 0 | 1 |
lysosomal alpha-glucosidase preproprotein | 1 | 0 | 0 | 1 |
Beta-casein | 0 | 1 | 0 | 1 |
Ribosyldihydronicotinamide dehydrogenase [quinone] | 0 | 1 | 0 | 1 |
Alpha-1B adrenergic receptor | 0 | 1 | 0 | 1 |
Alpha-2A adrenergic receptor | 0 | 1 | 0 | 1 |
D | 0 | 1 | 0 | 1 |
Alpha-mannosidase 2C1 | 0 | 0 | 1 | 1 |
Bromodomain-containing protein 2 | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 1B | 0 | 3 | 0 | 3 |
5-hydroxytryptamine receptor 1D | 0 | 1 | 0 | 1 |
Alpha-2B adrenergic receptor | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1F | 0 | 1 | 0 | 1 |
3-oxo-5-alpha-steroid 4-dehydrogenase 2 | 0 | 1 | 0 | 1 |
Type-1 angiotensin II receptor | 0 | 1 | 0 | 1 |
Alpha-2C adrenergic receptor | 0 | 1 | 0 | 1 |
Alpha-2A adrenergic receptor | 0 | 1 | 0 | 1 |
Alpha-2A adrenergic receptor | 0 | 1 | 0 | 1 |
Multidrug and toxin extrusion protein 2 | 0 | 1 | 0 | 1 |
Beta-1 adrenergic receptor | 0 | 1 | 1 | 3 |
Beta-2 adrenergic receptor | 0 | 2 | 0 | 3 |
Beta-1 adrenergic receptor | 0 | 2 | 1 | 4 |
D(3) dopamine receptor | 0 | 1 | 0 | 1 |
Beta-3 adrenergic receptor | 0 | 2 | 0 | 2 |
Neuromedin-K receptor | 0 | 0 | 1 | 1 |
Beta-1 adrenergic receptor | 0 | 1 | 0 | 1 |
Vasopressin V1a receptor | 0 | 1 | 1 | 2 |
Beta-2 adrenergic receptor | 0 | 1 | 0 | 1 |
Nuclear receptor subfamily 2 group E member 1 | 0 | 0 | 2 | 2 |
Squalene monooxygenase | 0 | 0 | 0 | 1 |
Cytochrome P450 3A5 | 0 | 1 | 0 | 1 |
Serine/threonine-protein kinase mTOR | 0 | 1 | 0 | 1 |
Peptidyl-prolyl cis-trans isomerase FKBP1A | 0 | 2 | 1 | 3 |
Peptidyl-prolyl cis-trans isomerase FKBP1B | 0 | 0 | 1 | 1 |
Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | 0 | 1 | 0 | 1 |
Peptidyl-prolyl cis-trans isomerase FKBP5 | 0 | 1 | 0 | 1 |
Splicing factor 3B subunit 3 | 0 | 1 | 0 | 1 |
ubiquitin carboxyl-terminal hydrolase 2 isoform a | 1 | 0 | 0 | 1 |
Disintegrin and metalloproteinase domain-containing protein 17 | 1 | 0 | 0 | 1 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |